1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Beyond Justice versus Efficiency – Reconciling Law and Economics approaches to Fairness
2024) p.91-130(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
A Neo-Kantian approach to Competition Law? – The re- emergence of Fairness in Antitrust Law & Policy
2024)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Compulsory License
2024)(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Compulsory Licensing as a Remedy Against Excessive Pricing of Life-Saving Medicines
2024) In South Centre Research Paper Series(
- Book/Report › Report
- 2023
-
Mark
Key issues for stakeholder engagement in the development of health and healthcare guidelines
(
- Contribution to journal › Article
-
Mark
Are excessive pricing cases few and far between? A quantitative analysis of fifty years of European jurisprudence 1971–2021
(
- Contribution to journal › Article
- 2022
-
Mark
The Giant Awakens : Law and Economics of Excessive Pricing During the COVID-19 Crisis
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Towards Fair Pricing of Medicines? Lessons from the European Commission's Aspen Decision
(
- Contribution to journal › Article
-
Mark
The Limits of Control – Competition law versus Sector Regulation in the wake of the European Commission Excessive Pricing Decision in Aspen
(
- Contribution to journal › Article
-
Mark
Temporary dominance and excessive pharmaceutical pricing - CD Pharma (Denmark)
2022) p.124-137(
- Chapter in Book/Report/Conference proceeding › Book chapter